Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;24(6):435–442. doi: 10.1002/clc.4960240604

The international EECP patient registry (IEPR): Design, methods, baseline characteristics, and acute results

Gregory Barsness 1, David R Holmes JR 1, Arthur M Feldman 2, Richard Holubkov 3, Sheryl F Kelsey 3, Elizabeth D Kennard 3,
PMCID: PMC6654842  PMID: 11403504

Abstract

Background: In 1998, the International EECP Patient Registry (IEPR) was organized to document patient characteristics, safety, and efficacy during the treatment period, and long‐term outcomes. All centers with EECP facilities were invited to join the voluntary Registry. The Registry population comprises all patients starting EECP therapy for treatment of angina pectoris in participating centers.

Hypothesis: The study was undertaken to determine whether EECP is a safe and effective treatment for patients with angina pectoris regardless of their suitability for revascularization by more conventional techniques.

Methods: After 18 months of operation, 43 clinical centers representing over half of clinical sites using the EECP system contributed cases. The data reported here were collected before the first EECP treatment and upon completion of final treatment. EECP can be used for patients ineligible for either coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI), as well as for those who prefer noninvasive treatment to avoid or delay revascularization. in this report, patients considered to be candidates for revascularization are compared with those not considered suitable.

Results: Of the 978 patients analyzed, 70% had Canadian Cardiovascular Society Classification class III or IV angina before starting treatment, and 62% used nitroglycerin. Most (81%) had been previously revascularized, and 69% were considered unsuited for either PCI or CABG at the time of starting EECP. A full treatment course (usually 35 h) was completed in 86%, of whom 81% reported improvement of at least one angina class immediately after the last treatment.

Conclusion: In a broad patient population, EECP has been shown to be a safe and effective treatment.

Keywords: external counterpulsation, angina pectoris, coronary artery disease, registry

Full Text

The Full Text of this article is available as a PDF (728.6 KB).

References

  • 1. Lawson WE, Hui JCK, Soroff HS, Zheng Z, Kayden DS, Sasvary D, Atkins H, Cohn P: Efficacy of enhanced external counterpulsation in the treatment of angina pectoris. Am J Cardiol 1992; 70: 859–862 [DOI] [PubMed] [Google Scholar]
  • 2. Lawson WE, Hui JCK, Zhen ZS, Oster Z, Katz JP, Diggs P, Burger L, Cohn C, Soroff H, Cohn P: Three‐year sustained benefit from enhanced external counterpulsation in chronic angina pectoris. Am J Cardiol 1995; 75: 840–841 [DOI] [PubMed] [Google Scholar]
  • 3. Zheng Z, Li T, Kambic H, Chen G, Yu I, Cai S, Zhan C, Chen Y, Wo S, Chen G, Ma H, Chen P, Huang B, Nose Y: Sequential external counterpulsation (SECP) in China. Trans Am Soc Artif Intern Organs 1983; 29: 599–603 [PubMed] [Google Scholar]
  • 4. Werner D, Hui JC, Kropp J, Daniel WG: Pneumatische externe Gegenpulsation—Therapieoption bei Angina pectoris. Z Cardiol 1998; 87 (suppl 2): 193–198 [DOI] [PubMed] [Google Scholar]
  • 5. Karim S, Sani A, Karo‐Karo S, Kasim M, Basha A, Gunadhi I, Japaries W, Suwita R: Enhanced external counterpulsation in the treatment and rehabilitation of coronary patients in Indonesia. Asian Cardiovasc Thor Ann 1995; 3: 26–28 [Google Scholar]
  • 6. Tartaglia J, Stenerson J: Case studies. Enhanced external counterpulsation. CVR & R 1997; 18: 26–33 [Google Scholar]
  • 7. Strobeck JE, Baklagian R, Hannen JC: The emerging role of enhanced external counterpulsation in cardiovascular disease management. CVR & R 1997; 18: 20–25 [PubMed] [Google Scholar]
  • 8. Soran O, Crawford LE, Schneider VM, Feldman AM: Enhanced external counterpulsation in the management of patients with cardiovascular disease. Clin Cardiol 1998; 22: 173–178 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Soroff HS, Hui JCK, Giron F: Historical review of the development of enhanced external counterpulsation technology and its physiological rationale. CVR & R 1997; 10: 34–40 [Google Scholar]
  • 10. Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T, Nesto R: The Multicenter Study of Enhanced External Counterpulsation (MUST‐EECP): Effect of EECP on exercise‐induced myocardial ischemia and anginal episodes. J Am Coll Cardiol 1999; 33: 1833–1840 [DOI] [PubMed] [Google Scholar]
  • 11. Campeau L: Grading of angina pectoris (Letter to the Editor). Circulation 1976; 54: 522–523 [PubMed] [Google Scholar]
  • 12. Arora RR, Chou TM, Diwakar J, Nesto R, Fleishman B, Crawford L, McKiernan T: Results of the Multicenter Enhanced External Counterpulsation (MUST‐EECP) Outcomes Study: Quality of life benefits sustained six months after treatment. Circulation 1998; 98: 1–350 9665051 [Google Scholar]
  • 13. Fricchione GL, Jaghab K, Lawson WE, Hui JC, Jandorf L, Zheng Z, Cohn P, Soroff H: Psychosocial effects of enhanced external counterpulsation in the angina patient. Psychosomatics 1995; 36 (5): 494–497 [DOI] [PubMed] [Google Scholar]
  • 14. Lawson WE, Hui JC, Cohn PF: Long‐term prognosis of patients with angina treated with enhanced external counterpulsation: Five‐year follow‐up study. Clin Cardiol 2000; 23: 254–258 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES